Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease.
Journal
Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041
Informations de publication
Date de publication:
10 Apr 2024
10 Apr 2024
Historique:
received:
11
12
2023
accepted:
18
03
2024
revised:
28
02
2024
medline:
10
4
2024
pubmed:
10
4
2024
entrez:
10
4
2024
Statut:
epublish
Résumé
The risk of developing Alzheimer's disease (AD) significantly increases in individuals carrying the APOEε4 allele. Elderly cognitively healthy individuals with APOEε4 also exist, suggesting the presence of cellular mechanisms that counteract the pathological effects of APOEε4; however, these mechanisms are unknown. We hypothesized that APOEε4 carriers without dementia might carry genetic variations that could protect them from developing APOEε4-mediated AD pathology. To test this, we leveraged whole-genome sequencing (WGS) data in the National Institute on Aging Alzheimer's Disease Family Based Study (NIA-AD FBS), Washington Heights/Inwood Columbia Aging Project (WHICAP), and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA) cohorts and identified potentially protective variants segregating exclusively among unaffected APOEε4 carriers. In homozygous unaffected carriers above 70 years old, we identified 510 rare coding variants. Pathway analysis of the genes harboring these variants showed significant enrichment in extracellular matrix (ECM)-related processes, suggesting protective effects of functional modifications in ECM proteins. We prioritized two genes that were highly represented in the ECM-related gene ontology terms, (FN1) and collagen type VI alpha 2 chain (COL6A2) and are known to be expressed at the blood-brain barrier (BBB), for postmortem validation and in vivo functional studies. An independent analysis in a large cohort of 7185 APOEε4 homozygous carriers found that rs140926439 variant in FN1 was protective of AD (OR = 0.29; 95% CI [0.11, 0.78], P = 0.014) and delayed age at onset of disease by 3.37 years (95% CI [0.42, 6.32], P = 0.025). The FN1 and COL6A2 protein levels were increased at the BBB in APOEε4 carriers with AD. Brain expression of cognitively unaffected homozygous APOEε4 carriers had significantly lower FN1 deposition and less reactive gliosis compared to homozygous APOEε4 carriers with AD, suggesting that FN1 might be a downstream driver of APOEε4-mediated AD-related pathology and cognitive decline. To validate our findings, we used zebrafish models with loss-of-function (LOF) mutations in fn1b-the ortholog for human FN1. We found that fibronectin LOF reduced gliosis, enhanced gliovascular remodeling, and potentiated the microglial response, suggesting that pathological accumulation of FN1 could impair toxic protein clearance, which is ameliorated with FN1 LOF. Our study suggests that vascular deposition of FN1 is related to the pathogenicity of APOEε4, and LOF variants in FN1 may reduce APOEε4-related AD risk, providing novel clues to potential therapeutic interventions targeting the ECM to mitigate AD risk.
Identifiants
pubmed: 38598053
doi: 10.1007/s00401-024-02721-1
pii: 10.1007/s00401-024-02721-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
70Subventions
Organisme : NIA NIH HHS
ID : R01AG067501
Pays : United States
Organisme : NIA NIH HHS
ID : RF1AG066107
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG072474
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Al-Yafeai Z, Yurdagul A Jr, Peretik JM, Alfaidi M, Murphy PA, Orr AW (2018) Endothelial FN (fibronectin) deposition by alpha5beta1 integrins drives atherogenic inflammation. Arterioscler Thromb Vasc Biol 38:2601–2614. https://doi.org/10.1161/ATVBAHA.118.311705
doi: 10.1161/ATVBAHA.118.311705
pubmed: 30354234
pmcid: 6209122
Alestrom P, D’Angelo L, Midtlyng PJ, Schorderet DF, Schulte-Merker S, Sohm F et al (2019) Zebrafish: housing and husbandry recommendations. Lab Anim. https://doi.org/10.1177/0023677219869037
doi: 10.1177/0023677219869037
pubmed: 31510859
pmcid: 7301644
Arora K, Shah M, Johnson M, Sanghvi R, Shelton J, Nagulapalli K et al (2019) Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms. Sci Rep 9:19123. https://doi.org/10.1038/s41598-019-55636-3
doi: 10.1038/s41598-019-55636-3
pubmed: 31836783
pmcid: 6911065
Bell CC (1994) DSM-IV: diagnostic and statistical manual of mental disorders. JAMA 272:828–829. https://doi.org/10.1001/jama.1994.03520100096046
doi: 10.1001/jama.1994.03520100096046
Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R et al (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68:409–427. https://doi.org/10.1016/j.neuron.2010.09.043
doi: 10.1016/j.neuron.2010.09.043
pubmed: 21040844
pmcid: 3056408
Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ et al (2023) Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical Alzheimer’s disease. Nat Med 29:1775–1781. https://doi.org/10.1038/s41591-023-02380-x
doi: 10.1038/s41591-023-02380-x
pubmed: 37248300
pmcid: 10353939
Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N et al (2022) New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. https://doi.org/10.1038/s41588-022-01024-z
doi: 10.1038/s41588-022-01024-z
pubmed: 36411364
pmcid: 9729101
Belloy ME, Eger SJ, Le Guen Y, Damotte V, Ahmad S, Ikram MA et al (2022) Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping. Alzheimers Res Ther 14:22. https://doi.org/10.1186/s13195-022-00962-4
doi: 10.1186/s13195-022-00962-4
pubmed: 35120553
pmcid: 8815198
Belloy ME, Andrews SJ, Le Guen Y, Cuccaro M, Farrer LA, Napolioni V et al (2023) APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol 80:1284–1294. https://doi.org/10.1001/jamaneurol.2023.3599
doi: 10.1001/jamaneurol.2023.3599
pubmed: 37930705
pmcid: 10628838
Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF et al (2006) Decision rules guiding the clinical diagnosis of Alzheimer’s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27:169–176. https://doi.org/10.1159/000096129
doi: 10.1159/000096129
pubmed: 17035694
Bhattarai P, Cosacak MI, Mashkaryan V, Demir S, Popova S, Govindarajan N et al (2020) Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer’s model of adult zebrafish brain. PLoS Biol 18:e3000585. https://doi.org/10.1371/journal.pbio.3000585
doi: 10.1371/journal.pbio.3000585
pubmed: 31905199
pmcid: 6964913
Bhattarai P, Thomas AK, Cosacak MI, Papadimitriou C, Mashkaryan V, Zhang Y et al (2017) Modeling amyloid-β42 toxicity and neurodegeneration in adult zebrafish brain. J Vis Exp. https://doi.org/10.3791/56014
doi: 10.3791/56014
pubmed: 29155703
pmcid: 5755241
Bhattarai P, Thomas AK, Papadimitriou C, Cosacak MI, Mashkaryan V, Froc C et al (2016) IL4/STAT6 signaling activates neural stem cell proliferation and neurogenesis upon Amyloid-β42 aggregation in adult zebrafish brain. Cell Rep 17:941–948. https://doi.org/10.1016/j.celrep.2016.09.075
doi: 10.1016/j.celrep.2016.09.075
pubmed: 27760324
Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM et al (2022) APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611:769–779. https://doi.org/10.1038/s41586-022-05439-w
doi: 10.1038/s41586-022-05439-w
pubmed: 36385529
pmcid: 9870060
Bogdan S, Puscion-Jakubik A, Klimiuk K, Socha K, Kochanowicz J, Gorodkiewicz E (2022) The concentration of fibronectin and MMP-1 in patients with Alzheimer's disease in relation to the selected antioxidant elements and eating habits. J Clin Med. https://doi.org/10.3390/jcm11216360
Burda JE, Sofroniew MV (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81:229–248. https://doi.org/10.1016/j.neuron.2013.12.034 . (S0896-6273(14)00011-7 [pii])
doi: 10.1016/j.neuron.2013.12.034
pubmed: 24462092
pmcid: 3984950
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K et al (2018) The UK Biobank resource with deep phenotyping and genomic data. Nature 562:203–209. https://doi.org/10.1038/s41586-018-0579-z
doi: 10.1038/s41586-018-0579-z
pubmed: 30305743
pmcid: 6786975
Cao L, Nicosia J, Larouche J, Zhang Y, Bachman H, Brown AC et al (2017) Detection of an integrin-binding mechanoswitch within fibronectin during tissue formation and fibrosis. ACS Nano 11:7110–7117. https://doi.org/10.1021/acsnano.7b02755
doi: 10.1021/acsnano.7b02755
pubmed: 28699736
pmcid: 5842356
Chen CY, Pollack S, Hunter DJ, Hirschhorn JN, Kraft P, Price AL (2013) Improved ancestry inference using weights from external reference panels. Bioinformatics 29(11):1399–1406. https://doi.org/10.1093/bioinformatics/btt144
doi: 10.1093/bioinformatics/btt144
pubmed: 23539302
pmcid: 3661048
Chhum P, Yu H, An B, Doyon BR, Lin YS, Brodsky B (2016) Consequences of glycine mutations in the fibronectin-binding sequence of collagen. J Biol Chem 291:27073–27086. https://doi.org/10.1074/jbc.M116.753566
doi: 10.1074/jbc.M116.753566
pubmed: 27799304
pmcid: 5207138
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923
doi: 10.1126/science.8346443
pubmed: 8346443
Cosacak MI, Bhattarai P, De Jager PL, Menon V, Tosto G, Kizil C (2022) Single cell/nucleus transcriptomics comparison in zebrafish and humans reveals common and distinct molecular responses to Alzheimer’s disease. Cells 11:1807. https://doi.org/10.3390/cells11111807
Cosacak MI, Bhattarai P, Kizil C (2020) Protocol for dissection and dissociation of zebrafish telencephalon for single-cell sequencing. STAR Protoc 1:100042. https://doi.org/10.1016/j.xpro.2020.100042
doi: 10.1016/j.xpro.2020.100042
pubmed: 32835293
pmcid: 7263268
Cosacak MI, Bhattarai P, Reinhardt S, Petzold A, Dahl A, Zhang Y et al (2019) Single-cell transcriptomics analyses of neural stem cell heterogeneity and contextual plasticity in a zebrafish brain model of amyloid toxicity. Cell Rep 27(1307–1318):e1303. https://doi.org/10.1016/j.celrep.2019.03.090
doi: 10.1016/j.celrep.2019.03.090
Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562–566. https://doi.org/10.1038/nature09513
doi: 10.1038/nature09513
pubmed: 20944625
pmcid: 3241506
Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A et al (2016) Next-generation genotype imputation service and methods. Nat Genet 48(10):1284–1287. https://doi.org/10.1038/ng.3656
doi: 10.1038/ng.3656
pubmed: 27571263
pmcid: 5157836
Drieu A, Du S, Storck SE, Rustenhoven J, Papadopoulos Z, Dykstra T et al (2022) Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid. Nature 611:585–593. https://doi.org/10.1038/s41586-022-05397-3
doi: 10.1038/s41586-022-05397-3
pubmed: 36352225
pmcid: 9899827
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356
doi: 10.1001/jama.1997.03550160069041
pubmed: 9343467
Fitch MT, Silver J (2008) CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 209:294–301. https://doi.org/10.1016/j.expneurol.2007.05.014 . (S0014-4886(07)00213-0 [pii])
doi: 10.1016/j.expneurol.2007.05.014
pubmed: 17617407
Geisler R, Borel N, Ferg M, Maier JV, Strahle U (2016) Maintenance of zebrafish lines at the European Zebrafish Resource Center. Zebrafish 13(Suppl 1):S19-23. https://doi.org/10.1089/zeb.2015.1205
doi: 10.1089/zeb.2015.1205
pubmed: 27351617
Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O et al (2011) APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16:903–907. https://doi.org/10.1038/mp.2011.52
doi: 10.1038/mp.2011.52
pubmed: 21556001
pmcid: 3162068
Gu Y, Beato JM, Amarante E, Chesebro AG, Manly JJ, Schupf N et al (2020) Assessment of leisure time physical activity and brain health in a multiethnic cohort of older adults. JAMA Netw Open 3:e2026506. https://doi.org/10.1001/jamanetworkopen.2020.26506
doi: 10.1001/jamanetworkopen.2020.26506
pubmed: 33211111
pmcid: 7677758
Guillon E, Das D, Julich D, Hassan AR, Geller H, Holley S (2020) Fibronectin is a smart adhesive that both influences and responds to the mechanics of early spinal column development. Elife. https://doi.org/10.7554/eLife.48964
doi: 10.7554/eLife.48964
pubmed: 32228864
pmcid: 7108867
Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA et al (2016) Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb Blood Flow Metab 36:216–227. https://doi.org/10.1038/jcbfm.2015.44
doi: 10.1038/jcbfm.2015.44
pubmed: 25757756
pmcid: 4758554
Hawkes CA, Gatherer M, Sharp MM, Dorr A, Yuen HM, Kalaria R et al (2013) Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-beta from the mouse brain. Aging Cell 12:224–236. https://doi.org/10.1111/acel.12045
doi: 10.1111/acel.12045
pubmed: 23413811
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405. https://doi.org/10.1016/S1474-4422(15)70016-5
doi: 10.1016/S1474-4422(15)70016-5
pubmed: 25792098
pmcid: 5909703
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572. https://doi.org/10.1192/bjp.140.6.566
doi: 10.1192/bjp.140.6.566
pubmed: 7104545
Iadecola C (2017) The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96:17–42. https://doi.org/10.1016/j.neuron.2017.07.030
doi: 10.1016/j.neuron.2017.07.030
pubmed: 28957666
pmcid: 5657612
İs O, Wang X, Patel T, Quicksall Z, Heckman M, White L et al (2022) Single nuclei transcriptome reveals perturbed brain vascular molecules in Alzheimer’s disease. Biorxiv. https://doi.org/10.1101/2021.12.28.474255
doi: 10.1101/2021.12.28.474255
Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262. https://doi.org/10.1016/j.jalz.2011.03.004
doi: 10.1016/j.jalz.2011.03.004
pubmed: 21514247
Jiang J, Wang C, Qi R, Fu H, Ma Q (2020) scREAD: a single-cell RNA-Seq database for Alzheimer’s disease. iScience 23:101769. https://doi.org/10.1016/j.isci.2020.101769
doi: 10.1016/j.isci.2020.101769
pubmed: 33241205
pmcid: 7674513
Kizil C, Sariya S, Kim YA, Rajabli F, Martin E, Reyes-Dumeyer D et al (2022) Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01526-6
doi: 10.1038/s41380-022-01526-6
pubmed: 35365809
pmcid: 9167722
Knox EG, Aburto MR, Clarke G, Cryan JF, O’Driscoll CM (2022) The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry 27:2659–2673. https://doi.org/10.1038/s41380-022-01511-z
doi: 10.1038/s41380-022-01511-z
pubmed: 35361905
pmcid: 9156404
Kohler A, Collymore C, Finger-Baier K, Geisler R, Kaufmann L, Pounder KC et al (2017) Report of workshop on euthanasia for zebrafish—a matter of welfare and science. Zebrafish 14:547–551. https://doi.org/10.1089/zeb.2017.1508
doi: 10.1089/zeb.2017.1508
pubmed: 28968196
pmcid: 5706616
Koizumi K, Hattori Y, Ahn SJ, Buendia I, Ciacciarelli A, Uekawa K et al (2018) Apoepsilon4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function. Nat Commun 9:3816. https://doi.org/10.1038/s41467-018-06301-2
doi: 10.1038/s41467-018-06301-2
pubmed: 30232327
pmcid: 6145902
Lathe R, Sapronova A, Kotelevtsev Y (2014) Atherosclerosis and Alzheimer–diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatr 14:36. https://doi.org/10.1186/1471-2318-14-36
doi: 10.1186/1471-2318-14-36
pubmed: 24656052
pmcid: 3994432
Lee AJ, Raghavan NS, Bhattarai P, Siddiqui T, Sariya S, Reyes-Dumeyer D, Flowers XE, Cardoso SAL, De Jager PL, Bennett DA et al (2022) FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease. Acta Neuropathol. https://doi.org/10.1007/s00401-022-02431-6
Lepelletier FX, Mann DM, Robinson AC, Pinteaux E, Boutin H (2017) Early changes in extracellular matrix in Alzheimer’s disease. Neuropathol Appl Neurobiol 43:167–182. https://doi.org/10.1111/nan.12295
doi: 10.1111/nan.12295
pubmed: 26544797
Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ et al (2019) Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570:332–337. https://doi.org/10.1038/s41586-019-1195-2
doi: 10.1038/s41586-019-1195-2
pubmed: 31042697
pmcid: 6865822
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944. https://doi.org/10.1212/wnl.34.7.939
doi: 10.1212/wnl.34.7.939
pubmed: 6610841
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269. https://doi.org/10.1016/j.jalz.2011.03.005
doi: 10.1016/j.jalz.2011.03.005
pubmed: 21514250
Michalski D, Spielvogel E, Puchta J, Reimann W, Barthel H, Nitzsche B et al (2020) Increased immunosignals of collagen IV and fibronectin indicate ischemic consequences for the neurovascular matrix adhesion zone in various animal models and human stroke tissue. Front Physiol 11:575598. https://doi.org/10.3389/fphys.2020.575598
doi: 10.3389/fphys.2020.575598
pubmed: 33192578
pmcid: 7649770
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486. https://doi.org/10.1212/wnl.41.4.479
doi: 10.1212/wnl.41.4.479
pubmed: 2011243
Mo FE (2021) Shear-regulated extracellular microenvironments and endothelial cell surface integrin receptors intertwine in atherosclerosis. Front Cell Dev Biol 9:640781. https://doi.org/10.3389/fcell.2021.640781
doi: 10.3389/fcell.2021.640781
pubmed: 33889574
pmcid: 8056009
Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A et al (2020) APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581:71–76. https://doi.org/10.1038/s41586-020-2247-3
doi: 10.1038/s41586-020-2247-3
pubmed: 32376954
pmcid: 7250000
Montagne A, Nikolakopoulou AM, Huuskonen MT, Sagare AP, Lawson EJ, Lazic D et al (2021) APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-beta. Nat Aging 1:506–520. https://doi.org/10.1038/s43587-021-00073-z
doi: 10.1038/s43587-021-00073-z
pubmed: 35291561
pmcid: 8920485
Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414. https://doi.org/10.1212/wnl.43.11.2412-a
doi: 10.1212/wnl.43.11.2412-a
pubmed: 8232972
Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M et al (1997) Clinical dementia rating training and reliability in multicenter studies: the Alzheimer’s Disease Cooperative Study experience. Neurology 48:1508–1510
doi: 10.1212/WNL.48.6.1508
pubmed: 9191756
Murdock MH, Tsai LH (2023) Insights into Alzheimer’s disease from single-cell genomic approaches. Nat Neurosci 26:181–195. https://doi.org/10.1038/s41593-022-01222-2
doi: 10.1038/s41593-022-01222-2
pubmed: 36593328
pmcid: 10155598
Ogino E, Manly JJ, Schupf N, Mayeux R, Gu Y (2019) Current and past leisure time physical activity in relation to risk of Alzheimer’s disease in older adults. Alzheimers Dement 15:1603–1611. https://doi.org/10.1016/j.jalz.2019.07.013
doi: 10.1016/j.jalz.2019.07.013
pubmed: 31587996
Okuyama K, Miyama K, Morimoto T, Masakiyo K, Mizuno K, Bachinger HP (2011) Stabilization of triple-helical structures of collagen peptides containing a Hyp-Thr-Gly, Hyp-Val-Gly, or Hyp-Ser-Gly sequence. Biopolymers 95:628–640. https://doi.org/10.1002/bip.21625
doi: 10.1002/bip.21625
pubmed: 21442606
Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor. Neuron 17:553–565
doi: 10.1016/S0896-6273(00)80187-7
pubmed: 8816718
Patel T, Carnwath TP, Wang X, Allen M, Lincoln SJ, Lewis-Tuffin LJ et al (2022) Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations. Aging Cell 21:e13606. https://doi.org/10.1111/acel.13606
doi: 10.1111/acel.13606
pubmed: 35388616
pmcid: 9124307
Reitz C, Pericak-Vance MA, Foroud T, Mayeux R (2023) A global view of the genetic basis of Alzheimer disease. Nat Rev Neurol. https://doi.org/10.1038/s41582-023-00789-z
doi: 10.1038/s41582-023-00789-z
pubmed: 37024647
pmcid: 10686263
Ruiz-Grosso P, Loret de Mola C, Vega-Dienstmaier JM, Arevalo JM, Chavez K, Vilela A et al (2012) Validation of the Spanish Center for Epidemiological Studies Depression and Zung Self-Rating Depression Scales: a comparative validation study. PLoS ONE 7:e45413. https://doi.org/10.1371/journal.pone.0045413
doi: 10.1371/journal.pone.0045413
pubmed: 23056202
pmcid: 3466285
Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A et al (2013) Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 4:2932. https://doi.org/10.1038/ncomms3932
doi: 10.1038/ncomms3932
pubmed: 24336108
Salloway S, Gur T, Berzin T, Tavares R, Zipser B, Correia S et al (2002) Effect of APOE genotype on microvascular basement membrane in Alzheimer’s disease. J Neurol Sci 203–204:183–187. https://doi.org/10.1016/s0022-510x(02)00288-5
doi: 10.1016/s0022-510x(02)00288-5
pubmed: 12417381
Sariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B et al (2021) Polygenic risk score for Alzheimer’s disease in Caribbean Hispanics. Ann Neurol 90:366–376. https://doi.org/10.1002/ana.26131
doi: 10.1002/ana.26131
pubmed: 34038570
pmcid: 8435026
Schumacher S, Dedden D, Nunez RV, Matoba K, Takagi J, Biertumpfel C et al (2021) Structural insights into integrin alpha(5)beta(1) opening by fibronectin ligand. Sci Adv. https://doi.org/10.1126/sciadv.abe9716
doi: 10.1126/sciadv.abe9716
pubmed: 33962943
pmcid: 8104898
Sepulveda-Falla D, Sanchez JS, Almeida MC, Boassa D, Acosta-Uribe J, Vila-Castelar C et al (2022) Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia. Acta Neuropathol 144:589–601. https://doi.org/10.1007/s00401-022-02467-8
doi: 10.1007/s00401-022-02467-8
pubmed: 35838824
pmcid: 9381462
Siddiqui T, Cosacak MI, Popova S, Bhattarai P, Santa-Maria I, Tosto G et al (2022) Neurogenic induction by Ngfr reduces reactive astrocytic Lcn2/Slc22a17 signalling, amyloid deposition and Tau phosphorylation. bioRxiv. https://doi.org/10.1101/2022.08.20.504608
doi: 10.1101/2022.08.20.504608
Siddiqui T, Cosacak MI, Popova S, Bhattarai P, Yilmaz E, Lee AJ et al (2023) Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s disease. NPJ Regener Med 8:33. https://doi.org/10.1038/s41536-023-00311-5
doi: 10.1038/s41536-023-00311-5
Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5:146–156. https://doi.org/10.1038/nrn1326 . (nrn1326 [pii])
doi: 10.1038/nrn1326
pubmed: 14735117
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia 7:280–292. https://doi.org/10.1016/j.jalz.2011.03.003
doi: 10.1016/j.jalz.2011.03.003
pubmed: 21514248
Stallones L, Marx MB, Garrity TF (1990) Prevalence and correlates of depressive symptoms among older U.S. adults. Am J Prev Med 6:295–303
doi: 10.1016/S0749-3797(18)30998-X
pubmed: 2268457
Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, Lantigua R et al (1992) Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 49:453–460
doi: 10.1001/archneur.1992.00530290035009
pubmed: 1580806
Strahle U, Scholz S, Geisler R, Greiner P, Hollert H, Rastegar S et al (2012) Zebrafish embryos as an alternative to animal experiments–a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod Toxicol 33:128–132. https://doi.org/10.1016/j.reprotox.2011.06.121
doi: 10.1016/j.reprotox.2011.06.121
pubmed: 21726626
Sun L, Zou Z, Collodi P, Xu F, Xu X, Zhao Q (2005) Identification and characterization of a second fibronectin gene in zebrafish. Matrix Biol 24:69–77. https://doi.org/10.1016/j.matbio.2004.12.002
doi: 10.1016/j.matbio.2004.12.002
pubmed: 15749003
Sun N, Akay LA, Murdock MH, Park Y, Galiana-Melendez F, Bubnys A et al (2023) Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer’s disease. Nat Neurosci 26:970–982. https://doi.org/10.1038/s41593-023-01334-3
doi: 10.1038/s41593-023-01334-3
pubmed: 37264161
pmcid: 10464935
Sun Y, Xu S, Jiang M, Liu X, Yang L, Bai Z et al (2021) Role of the extracellular matrix in Alzheimer’s disease. Front Aging Neurosci 13:707466. https://doi.org/10.3389/fnagi.2021.707466
doi: 10.3389/fnagi.2021.707466
pubmed: 34512308
pmcid: 8430252
Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R et al (2021) Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590(7845):290–299. https://doi.org/10.1038/s41586-021-03205-y
doi: 10.1038/s41586-021-03205-y
pubmed: 33568819
pmcid: 7875770
Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R et al (1998) The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279:751–755
doi: 10.1001/jama.279.10.751
pubmed: 9508150
Thomsen MS, Birkelund S, Burkhart A, Stensballe A, Moos T (2017) Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier. J Neurochem 140:741–754. https://doi.org/10.1111/jnc.13747
doi: 10.1111/jnc.13747
pubmed: 27456748
Thomsen MS, Routhe LJ, Moos T (2017) The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab 37:3300–3317. https://doi.org/10.1177/0271678X17722436
doi: 10.1177/0271678X17722436
pubmed: 28753105
pmcid: 5624399
Tosto G, Fu H, Vardarajan BN, Lee JH, Cheng R, Reyes-Dumeyer D et al (2015) F-box/LRR-repeat protein 7 is genetically associated with Alzheimer’s disease. Ann Clin Transl Neurol 2:810–820. https://doi.org/10.1002/acn3.223
doi: 10.1002/acn3.223
pubmed: 26339675
pmcid: 4554442
Vardarajan BN, Faber KM, Bird TD, Bennett DA, Rosenberg R, Boeve BF et al (2014) Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol 71:315–323. https://doi.org/10.1001/jamaneurol.2013.5570
doi: 10.1001/jamaneurol.2013.5570
pubmed: 24425039
pmcid: 4000602
Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RL (2006) Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc 1:2719–2732. https://doi.org/10.1038/nprot.2006.354
doi: 10.1038/nprot.2006.354
pubmed: 17406528
Wang X, Allen M, Li S, Quicksall ZS, Patel TA, Carnwath TP et al (2020) Deciphering cellular transcriptional alterations in Alzheimer’s disease brains. Mol Neurodegener 15:38. https://doi.org/10.1186/s13024-020-00392-6
doi: 10.1186/s13024-020-00392-6
pubmed: 32660529
pmcid: 7359236
Xiong M, Wang C, Gratuze M, Saadi F, Bao X, Bosch ME et al (2023) Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy. Mol Neurodegener 18:17. https://doi.org/10.1186/s13024-023-00610-x
doi: 10.1186/s13024-023-00610-x
pubmed: 36922879
pmcid: 10018855
Xu L, Nirwane A, Yao Y (2019) Basement membrane and blood-brain barrier. Stroke Vasc Neurol 4:78–82. https://doi.org/10.1136/svn-2018-000198
doi: 10.1136/svn-2018-000198
pubmed: 31338215
Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15:501–518. https://doi.org/10.1038/s41582-019-0228-7
doi: 10.1038/s41582-019-0228-7
pubmed: 31367008
pmcid: 7055192
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA et al (2022) A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature 603:885–892. https://doi.org/10.1038/s41586-021-04369-3
doi: 10.1038/s41586-021-04369-3
pubmed: 35165441
pmcid: 9635042
Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG et al (2012) Genomic analysis of reactive astrogliosis. J Neurosci 32:6391–6410. https://doi.org/10.1523/JNEUROSCI.6221-11.2012
doi: 10.1523/JNEUROSCI.6221-11.2012
pubmed: 22553043
pmcid: 3480225
Zheng H, Lu C, Lan J, Fan S, Nanda V, Xu F (2018) How electrostatic networks modulate specificity and stability of collagen. Proc Natl Acad Sci USA 115:6207–6212. https://doi.org/10.1073/pnas.1802171115
doi: 10.1073/pnas.1802171115
pubmed: 29844169
pmcid: 6004475
Zou L, Cao S, Kang N, Huebert RC, Shah VH (2012) Fibronectin induces endothelial cell migration through beta1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766. J Biol Chem 287:7190–7202. https://doi.org/10.1074/jbc.M111.304972
doi: 10.1074/jbc.M111.304972
pubmed: 22247553
pmcid: 3293564